Profile data is unavailable for this security.
About the company
Shanghai Shen Lian Biomedical Corp is a China-based company mainly engaged in the research, development, production and sales of veterinary biological products. The Company is committed to the research & development of foot and mouth disease vaccines, which are used to protect animals from foot and mouth diseases. The Company's main product are swine foot and mouth disease vaccines, and it also provides cattle foot and mouth disease vaccines, other swine vaccines, and other veterinary diagnostic reagents. The Company mainly sells its products within domestic market.
- Revenue in CNY (TTM)281.44m
- Net income in CNY25.86m
- Incorporated2001
- Employees365.00
- LocationShanghai Shen Lian Biomedical CorpNo. 48Jiangchuan East Road, Minhang DistrictSHANGHAI 200241ChinaCHN
- Phone+86 2 161257979
- Fax+86 2 161267296
- Websitehttp://www.slbio.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Shengda Bio-pharm Co Ltd | 742.96m | -53.74m | 2.04bn | 1.03k | -- | 1.63 | -- | 2.75 | -0.3325 | -0.3325 | 4.27 | 7.31 | 0.4409 | 2.33 | 6.08 | 719,919.20 | -3.10 | 3.39 | -3.71 | 4.42 | 15.03 | 28.58 | -7.02 | 7.57 | 1.41 | -- | 0.2268 | 39.98 | -1.44 | 8.10 | -271.70 | -- | 11.22 | -6.89 |
| Shanghai Jiaoda Onlly Co Ltd | 280.54m | -39.86m | 2.05bn | 935.00 | -- | 7.02 | -- | 7.29 | -0.0514 | -0.0514 | 0.362 | 0.3761 | 0.3475 | 5.15 | 4.63 | 300,042.20 | -4.64 | -7.62 | -7.62 | -10.70 | 18.03 | 40.06 | -13.36 | -27.01 | 0.6301 | -1.40 | 0.3455 | -- | -21.43 | 2.65 | 92.96 | -- | -34.81 | -- |
| Jiangsu gdk Biotechnology Co Ltd | 33.39m | -128.83m | 2.07bn | 451.00 | -- | 1.54 | -- | 62.10 | -1.04 | -1.04 | 0.2686 | 10.95 | 0.0193 | 0.4185 | 0.1529 | 74,034.57 | -7.45 | 3.30 | -8.73 | 4.84 | 51.14 | 75.56 | -385.83 | 12.58 | 3.20 | -- | 0.048 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
| Shanghai Shen Lian Biomedical Corp | 281.44m | 25.86m | 2.16bn | 365.00 | 83.69 | 1.44 | -- | 7.69 | 0.063 | 0.063 | 0.6854 | 3.66 | 0.1731 | 0.7474 | 0.9025 | 771,056.40 | 1.54 | 6.85 | 1.65 | 7.54 | 70.64 | 79.21 | 8.92 | 29.63 | 6.58 | -- | 0.0008 | 30.78 | -8.32 | 1.70 | -44.56 | -9.14 | -2.08 | -- |
| Jiangsu Cowin Biotech Co Ltd | 123.20m | -117.37m | 2.21bn | 657.00 | -- | 1.36 | -- | 17.95 | -1.12 | -1.12 | 1.21 | 14.49 | 0.0664 | 1.33 | 1.23 | 187,520.90 | -6.63 | -- | -6.94 | -- | 58.15 | -- | -99.82 | -- | 14.37 | -- | 0.0184 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 384.44m | 26.95m | 2.25bn | 787.00 | 83.07 | 3.08 | -- | 5.84 | 0.0708 | 0.0708 | 1.01 | 1.91 | 0.367 | 1.38 | 1.79 | 488,492.20 | 2.57 | -4.59 | 3.60 | -6.24 | 48.38 | 29.54 | 7.01 | -18.40 | 1.44 | -- | 0.0021 | -- | 5.54 | -2.50 | 137.33 | -- | -21.00 | -- |
Data as of May 28 2024. Currency figures normalised to Shanghai Shen Lian Biomedical Corp's reporting currency: Chinese Yuan Renminbi CNY
4.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 3.69m | 1.46% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 2.86m | 1.13% |
| Zhong Geng Fund Management Co. , Ltd.as of 31 Dec 2023 | 850.43k | 0.34% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 822.03k | 0.33% |
| Essence Fund Co., Ltd.as of 31 Dec 2023 | 782.37k | 0.31% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 582.96k | 0.23% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 452.21k | 0.18% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 399.80k | 0.16% |
| Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 290.20k | 0.12% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 244.80k | 0.10% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
